Skip to main navigation Skip to search Skip to main content

Further evidence for the association of GAL, GALR1 and NPY1R variants with opioid dependence

  • Matthew Randesi*
  • , Orna Levran
  • , Wim van den Brink
  • , Peter Blanken
  • , Jan M. van Ree
  • , Jurg Ott
  • , Mary J. Kreek
  • *Corresponding author for this work
  • Rockefeller University
  • Parnassia Addiction Research Centre (Brijder Addiction Treatment)
  • University Medical Center Utrecht

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Aim: Heroin addiction is a chronic, relapsing disease that has genetic and environmental, including drug-induced, contributions. Stress influences the development of addictions. This study was conducted to determine if variants in stress-related genes are associated with opioid dependence (OD). Patients & methods: One hundred and twenty variants in 26 genes were analyzed in 597 Dutch subjects. Patients included 281 OD in methadone maintenance with or without heroin-assisted treatment and 316 controls. Results: Twelve SNPs in seven genes showed a nominally significant association with OD. Experiment-wise significant associations (p < 0.05) were found for three SNP pairs, through an interaction effect: NPY1R/GAL rs4691910/rs1893679, NPY1R/GAL rs4691910/rs3136541 and GALR1/GAL rs9807208/rs3136541. Conclusion: This study lends more evidence to previous reports of association of stress-related variants with heroin dependence.
Original languageEnglish
Pages (from-to)903-917
JournalPharmacogenomics
Volume21
Issue number13
DOIs
Publication statusPublished - 1 Aug 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Further evidence for the association of GAL, GALR1 and NPY1R variants with opioid dependence'. Together they form a unique fingerprint.

Cite this